Fig. 3From: Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMARadiolysed [177Lu]Lu-PSMA-I&T with a RCP varying from clinical labeling [97% (red)] and degraded radiopharmaceutical [90% (green), 70% (blue) and 50% (black)] for the cell-uptake assayBack to article page